AU2001260455A1 - Cyclic amino acid derivatives useful as pharmaceutical agents - Google Patents
Cyclic amino acid derivatives useful as pharmaceutical agentsInfo
- Publication number
- AU2001260455A1 AU2001260455A1 AU2001260455A AU6045501A AU2001260455A1 AU 2001260455 A1 AU2001260455 A1 AU 2001260455A1 AU 2001260455 A AU2001260455 A AU 2001260455A AU 6045501 A AU6045501 A AU 6045501A AU 2001260455 A1 AU2001260455 A1 AU 2001260455A1
- Authority
- AU
- Australia
- Prior art keywords
- amino acid
- acid derivatives
- pharmaceutical agents
- cyclic amino
- derivatives useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
- C07C205/42—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/43—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/84—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0012850A GB2362646A (en) | 2000-05-26 | 2000-05-26 | Cyclic amino acid derivatives useful as pharmaceutical agents |
GB0012850 | 2000-05-26 | ||
PCT/GB2001/002353 WO2001090052A1 (en) | 2000-05-26 | 2001-05-25 | Cyclic amino acid derivatives useful as pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001260455A1 true AU2001260455A1 (en) | 2001-12-03 |
Family
ID=9892438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001260455A Abandoned AU2001260455A1 (en) | 2000-05-26 | 2001-05-25 | Cyclic amino acid derivatives useful as pharmaceutical agents |
Country Status (9)
Country | Link |
---|---|
US (2) | US20030216469A1 (en) |
EP (1) | EP1284960A1 (en) |
JP (1) | JP2003534312A (en) |
AU (1) | AU2001260455A1 (en) |
BR (1) | BR0111126A (en) |
CA (1) | CA2409768A1 (en) |
GB (1) | GB2362646A (en) |
MX (1) | MXPA02011262A (en) |
WO (1) | WO2001090052A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7164034B2 (en) | 1999-06-10 | 2007-01-16 | Pfizer Inc. | Alpha2delta ligands for fibromyalgia and other disorders |
AU2002345638A1 (en) | 2001-06-11 | 2002-12-23 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
NZ567711A (en) * | 2001-06-11 | 2009-10-30 | Xenoport Inc | Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP1485082A4 (en) * | 2002-02-19 | 2009-12-30 | Xenoport Inc | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
US7025745B2 (en) * | 2002-10-07 | 2006-04-11 | Advanced Cardiovascular Systems, Inc. | Method of making a catheter balloon using a tapered mandrel |
KR20050085563A (en) | 2002-12-13 | 2005-08-29 | 워너-램버트 캄파니 엘엘씨 | Alpha-2-delta ligand to treat lower urinary tract symptoms |
JP2006513257A (en) | 2002-12-13 | 2006-04-20 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Pregabalin derivatives for treating fibromyalgia and other disorders |
ITMI20022658A1 (en) * | 2002-12-17 | 2004-06-18 | Nicox Sa | DRUGS FOR CHRONIC PAIN. |
TW589176B (en) * | 2002-12-31 | 2004-06-01 | Ind Tech Res Inst | Gabapentin derivatives |
EP2354120A1 (en) | 2003-08-20 | 2011-08-10 | XenoPort, Inc. | Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
PT1660440E (en) | 2003-08-20 | 2012-05-15 | Xenoport Inc | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
EP1670451A4 (en) * | 2003-09-11 | 2009-10-21 | Xenoport Inc | Treating and/or preventing urinary incontinence using prodrugs of gaba analogs |
BRPI0414343A (en) | 2003-09-12 | 2006-11-07 | Pfizer | combinations comprising alpha-2-delta ligands and serotonin / norepinephrine reuptake inhibitors |
EP1677812A4 (en) | 2003-09-17 | 2010-03-24 | Xenoport Inc | Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
MXPA06004088A (en) | 2003-10-14 | 2006-06-27 | Xenoport Inc | Crystalline form of gamma-aminobutyric acid analog. |
US20050209319A1 (en) * | 2004-03-18 | 2005-09-22 | Xenoport, Inc. | Treatment of local pain |
KR101228399B1 (en) | 2004-11-04 | 2013-01-31 | 제노포트 인코포레이티드 | Gabapentin prodrug sustained release oral dosage forms |
AU2007325686A1 (en) * | 2006-11-30 | 2008-06-05 | Cenerx Biopharma, Inc. | Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
EP2101752A1 (en) * | 2006-12-08 | 2009-09-23 | Xenoport, Inc. | Use of prodrugs of gaba analogs for treating diseases |
JP5308350B2 (en) | 2006-12-22 | 2013-10-09 | レコルダーティ アイルランド リミテッド | Combination therapy of lower urinary tract dysfunction using α2δ ligand and NSAID |
CN101555214B (en) * | 2008-04-08 | 2012-07-11 | 北京嘉事联博医药科技有限公司 | Phenylcyclobutylacylamide derivative as well as optical isomer, preparation method and application thereof |
FR2931151A1 (en) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | NOVEL AMINO ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE |
CN102341099A (en) | 2009-03-03 | 2012-02-01 | 什诺波特有限公司 | Sustained release oral dosage forms of an R-baclofen prodrug |
WO2011101245A1 (en) | 2010-02-18 | 2011-08-25 | Nicox S.A. | Nitric oxide releasing compounds for the treatment of neuropathic pain |
CN107050456B (en) | 2010-09-28 | 2022-08-12 | 加利福尼亚大学董事会 | GABA agonists for the treatment of diseases associated with metabolic syndrome and GABA combinations for the treatment or prevention of type I diabetes |
WO2013023155A1 (en) | 2011-08-11 | 2013-02-14 | Xenoport, Inc. | Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use |
WO2017087594A1 (en) | 2015-11-19 | 2017-05-26 | Biohaven Pharmaceutical Holding Company Ltd. | Amine prodrugs of pharmaceutical compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (en) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-aminomethyl-1-cycloalkaneacetic acids and their esters, processes for their preparation and medicaments containing these compounds |
DE2611690A1 (en) * | 1976-03-19 | 1977-09-22 | Goedecke Ag | CYCLIC SULFONYLOXYIMIDE |
DE2626467C2 (en) * | 1976-06-12 | 1984-11-22 | Gödecke AG, 1000 Berlin | 1- (N-Isopropylaminomethyl) -cyclohexaneacetic acid, process for the preparation thereof and medicaments containing this compound |
US4760057A (en) * | 1983-06-23 | 1988-07-26 | Merck & Co., Inc. | (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs |
KR100512506B1 (en) * | 1996-03-14 | 2005-12-21 | 워너-램버트 캄파니 엘엘씨 | Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents |
US6635673B1 (en) * | 1997-10-27 | 2003-10-21 | Warner-Lambert Company | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
EP1047678B1 (en) * | 1997-12-16 | 2004-09-08 | Warner-Lambert Company LLC | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
-
2000
- 2000-05-26 GB GB0012850A patent/GB2362646A/en not_active Withdrawn
-
2001
- 2001-05-25 JP JP2001586242A patent/JP2003534312A/en active Pending
- 2001-05-25 MX MXPA02011262A patent/MXPA02011262A/en unknown
- 2001-05-25 US US10/296,355 patent/US20030216469A1/en not_active Abandoned
- 2001-05-25 WO PCT/GB2001/002353 patent/WO2001090052A1/en not_active Application Discontinuation
- 2001-05-25 EP EP01934149A patent/EP1284960A1/en not_active Withdrawn
- 2001-05-25 CA CA002409768A patent/CA2409768A1/en not_active Abandoned
- 2001-05-25 AU AU2001260455A patent/AU2001260455A1/en not_active Abandoned
- 2001-05-25 BR BR0111126-4A patent/BR0111126A/en not_active Application Discontinuation
-
2004
- 2004-10-28 US US10/975,675 patent/US20050059735A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0012850D0 (en) | 2000-07-19 |
BR0111126A (en) | 2003-12-30 |
CA2409768A1 (en) | 2001-11-29 |
WO2001090052A1 (en) | 2001-11-29 |
US20050059735A1 (en) | 2005-03-17 |
EP1284960A1 (en) | 2003-02-26 |
GB2362646A (en) | 2001-11-28 |
US20030216469A1 (en) | 2003-11-20 |
JP2003534312A (en) | 2003-11-18 |
MXPA02011262A (en) | 2003-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001260455A1 (en) | Cyclic amino acid derivatives useful as pharmaceutical agents | |
GB0018828D0 (en) | Alkyl Amino Acid Derivatives useful as pharmaceutical agents | |
EG25614A (en) | Novel pyrroles derivatives as pharmaceutical agents | |
AU2001280187A1 (en) | Cyclic amine derivatives | |
AU2001234175A1 (en) | Novel cyclic amide derivatives | |
AU2002234645A1 (en) | Amino dicarboxylic acid derivatives with pharmaceutical properties | |
AU1928501A (en) | Formulations for pharmaceutical agents ionizable as free acids or free bases | |
HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
AU2002257582A1 (en) | Pharmaceutical formulation | |
AU1433901A (en) | Excitatory amino acid derivatives | |
AU2001280167A1 (en) | Novel propenohydroxamic acid derivatives | |
AU6038601A (en) | Amino acid derivatives and their use as medicines | |
AU2001292122A1 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
AU2002350942A1 (en) | Imidazolidineacetic acid derivatives | |
AU2001228454A1 (en) | Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary | |
AU3232701A (en) | Processes for preparing optically active amino acid derivatives | |
GB0014851D0 (en) | Novel pharmaceutical formulation | |
AU2001246541A1 (en) | Novel alpha-sulfin- and alpha-sulfonamino acid amide derivatives | |
GB0014892D0 (en) | Novel pharmaceutical formulation | |
GB0014883D0 (en) | Novel pharmaceutical formulation | |
GB0014947D0 (en) | Novel pharmaceutical formulation | |
AU2002358879A1 (en) | Polymer-structured composition containing lipophilic amino acid derivatives | |
AU2002315287A1 (en) | Pharmaceutical composition comprising clavulanic acid | |
AUPQ896500A0 (en) | Amino acid derivatives | |
AU2001263853A1 (en) | Alpha-sulfin- and alpha-sulfonamino acid amide derivatives |